Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO's objective: allowing EU research to continue unhindered  

Clinical Trials Regulation

The Regulation came into effect in 2014 and acknowledges the importance of data stored for a clinical trial to be used beyond the end of a clinical trial, for research purposes, and ensures that medical research will be able to continue in a smooth manner. It will become law in all EU Member States six months after the European Medicines Agency has created the EU single portal and database and they are fully functional (but not earlier than two years after the regulation's publication, which means earliest in 2016).

Data Protection Regulation

The ESMO position paper on the EU General Data Protection Regulation seeks to raise awareness with EU decision-makers that their legitimate response to citizens’ concerns on data security should not hinder the much-needed work of public health researchers and their appropriate access to data, acknowledging that strict safeguards protecting medical data are already in place.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.